Actively Recruiting
Temporal and Dose-response Effects of Nicotinamide Riboside Supplementation on Metabolic Flexibility During Zone 2 Training in Adults: A Double-blinded, Randomized, Controlled, Crossover Trial
Led by ZHANG Jiaqi · Updated on 2026-03-18
16
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating how nicotinamide riboside (NR) supplementation affects metabolic flexibility and exercise performance during Zone 2 cycling training in healthy adults. Zone 2 training is a low-intensity endurance exercise performed near the first ventilatory threshold that improves aerobic capacity, fat metabolism, and mitochondrial efficiency. This study seeks to clarify potential interactions between NR, a dietary supplement involved in cellular energy metabolism, and this type of endurance training. Participants will undergo a double-blinded, randomized, controlled, crossover trial comparing different doses of NR supplementation—600 mg, 300 mg, and no supplementation—during Zone 2 cycling training. The intervention lasts four weeks, focusing on the temporal and dose-dependent effects of NR combined with exercise. The study evaluates how NR supplementation influences substrate utilization, energy production, and fatigue resistance during low-intensity endurance training. Throughout the trial, researchers will monitor participants' substrate use (carbohydrate and fat oxidation rates), oxygen consumption, heart rate, blood glucose and lactate levels, peak and mean power output, perceived exertion, muscle pain, and muscle fatigue from enrollment through the four-week treatment. This comprehensive assessment aims to measure metabolic flexibility and exercise performance changes related to NR supplementation and Zone 2 training in adults aged 18 to 80 years.
CONDITIONS
Brief Title
Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years old
- Body mass index (BMI) less than 30 kg/m2
You will not qualify if you...
- Presence of health conditions that prevent exercise, such as cardiovascular disease, cancer, or musculoskeletal disorders
- Currently taking vitamin B supplements or NAD precursors
- Taking medications that may affect test results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks per treatment period
Participants receive different doses of Nicotinamide Riboside supplementation while undergoing Zone 2 training to assess metabolic flexibility.
Weekly visits for up to 4 weeks per treatment period
Trial Site Locations
Total: 1 location
1
G02, Kwok Sports Building, The Chinese University of Hong Kong
Hong Kong, Please Select, China, 999077
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here